Jeff Bolle, 60, died of cancer seven months after losing access to his chemotherapy drug amid the nationwide drug shortage.

Sometimes Connie Bolle wonders if her husband, Jeff Bolle, 60, would still be alive if things had been different last spring.

Traditionally, therapies combining DNA-damaging agents and STING agonists have shown potential in treating cancer by enhancing immune response and reshaping the tumor microenvironment. However, until ...

Cisplatin is a highly effective chemotherapy that has been used to treat cancer for decades, but it can cause kidney injury that can potentially lead to the discontinuation of life-saving cancer ...

Due to have six rounds of chemotherapy, an American football coach was denied his final two courses of cisplatin due to ...

The death of a Milwaukee high school football coach has drawn attention to national drug shortages, as his family speaks out about their inability to access life-saving treatment. Jeff Bolle, 60, died ...

In a recent study published in the BMJ, researchers created and validated a model to predict severe acute kidney injury in patients receiving cisplatin using data from various cancer centers.

Bristol Myers Squibb (BMY) announced the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has ...

So far, toripalimab has been approved for marketing in the Chinese mainland and the US. Several NDAs are currently under regulatory review in the European Union, UK, Australia, Singapore, Malaysia and ...

NICE is unable to make a recommendation on pembrolizumab (Keytruda) with gemcitabine and cisplatin for untreated advanced biliary tract cancer in adults. This is because Merck Sharp & Dohme did not ...